Velu, Priya

Publications

Sort by

Co-Author Network

selected publications

Deep computational image analysis of immune cell niches reveals treatment-specific outcome associations in lung cancer. NPJ precision oncology. 2023 Academic Article GET IT
Times cited: 2136
A tumor vasculature-based imaging biomarker for predicting response and survival in patients with lung cancer treated with checkpoint inhibitors. Science advances. 2022 Academic Article GET IT
Times cited: 1
Rapid detection of SARS-CoV-2 variants of concern by single nucleotide polymorphism genotyping using TaqMan assays. Diagnostic microbiology and infectious disease. 2022 Academic Article GET IT
Times cited: 1
Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists: A Report of the Association for Molecular Pathology Training and Education Committee. The Journal of molecular diagnostics : JMD. 2022 Review GET IT
Times cited: 2
Image analysis reveals molecularly distinct patterns of TILs in NSCLC associated with treatment outcome. NPJ precision oncology. 2022 Academic Article GET IT
Times cited: 126
Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors. Science advances. 2022 Academic Article GET IT
Times cited: 9
System-wide transcriptome damage and tissue identity loss in COVID-19 patients. Cell reports. Medicine. 2022 Academic Article GET IT
Times cited: 13
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile. Health data science. 2021 Academic Article GET IT
Times cited: 147
Next-Generation Sequencing of Cell-Free DNA Extracted From Pleural Effusion Supernatant: Applications and Challenges. Frontiers in medicine. 2021 Academic Article GET IT
Times cited: 2
Interpretative differences of combined cytogenetic and molecular profiling highlights differences between MRC and ELN classifications of AML. Cancer genetics. 2021 Academic Article GET IT
Times cited: 2
Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States. Cell. 2021 Academic Article GET IT
Times cited: 58
Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nature communications. 2021 Academic Article GET IT
Times cited: 67
Early introductions and community transmission of SARS-CoV-2 variant B.1.1.7 in the United States. medRxiv : the preprint server for health sciences. 2021 Article GET IT
Systemic Tissue and Cellular Disruption from SARS-CoV-2 Infection revealed in COVID-19 Autopsies and Spatial Omics Tissue Maps. bioRxiv : the preprint server for biology. 2021 Article GET IT
Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution. The Journal of molecular diagnostics : JMD. 2020 Academic Article GET IT
Times cited: 2
Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning. Clinical chemistry. 2020 Academic Article GET IT
Times cited: 62
Clinical Performance of SARS-CoV-2 Molecular Tests. Journal of clinical microbiology. 2020 Academic Article GET IT
Times cited: 66
Comparison of Two High-Throughput Reverse Transcription-PCR Systems for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2. Journal of clinical microbiology. 2020 Academic Article GET IT
Times cited: 43
Shotgun Transcriptome and Isothermal Profiling of SARS-CoV-2 Infection Reveals Unique Host Responses, Viral Diversification, and Drug Interactions. bioRxiv : the preprint server for biology. 2020 Article GET IT
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study. Lung cancer (Amsterdam, Netherlands). 2020 Academic Article GET IT
Times cited: 23
CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in Stage I, II resectable Non-Small Cell Lung Cancer: a retrospective multi-cohort study for outcome prediction. The Lancet. Digital health. 2020 Academic Article GET IT
Times cited: 62
CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction. The Lancet. Digital health. 2020 Academic Article GET IT
Times cited: 62
Changes in CT Radiomic Features Associated with Lymphocyte Distribution Predict Overall Survival and Response to Immunotherapy in Non-Small Cell Lung Cancer. Cancer immunology research. 2019 Academic Article GET IT
Times cited: 127
Longitudinal targeted next-generation sequencing in a patient with acute myeloid leukaemia. 2019 GET IT
Classes of ITD Predict Outcomes in AML Patients Treated with FLT3 Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Academic Article GET IT
Times cited: 10
Genomic heterogeneity of ALK fusion breakpoints in non-small-cell lung cancer. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2018 Academic Article GET IT
Times cited: 58
Hippocampus, perirhinal cortex, and complex visual discriminations in rats and humans. Learning & memory (Cold Spring Harbor, N.Y.). 2015 Academic Article GET IT
Times cited: 14
Effect of visual feedback on the occipital-parietal-motor network in Parkinson's disease with freezing of gait. Frontiers in neurology. 2014 Academic Article GET IT
Times cited: 417
Single-trial classification of gait and point movement preparation from human EEG. Frontiers in neuroscience. 2013 Academic Article GET IT
Times cited: 205
Charges in the hydrophobic interior of proteins. Proceedings of the National Academy of Sciences of the United States of America. 2010 Academic Article GET IT
Times cited: 169
Hydration of the folding transition state ensemble of a protein. Biochemistry. 2006 Academic Article GET IT
Times cited: 44

more ...

less ...

Background

education and training

M.D., University of California, San Diego School of Medicine 2014
Ph.D., University of California, San Diego 2014
B.A., The Johns Hopkins University 2005

Contact

full name

Priya Velu

primary email

prv9013@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Priya Velu Assistant Professor of Pathology and Laboratory Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage